Tsutomu Shimada

Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study

K. Suzuki, Takeharu Yamanaka, Hiroki Hashimoto et al. · Annals of Oncology · 2016 · 97 citations · Full text

Medicine, Oncology, Pharmacology +16

Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations

Shunji Tomatsu, Kazuki Sawamoto, Tsutomu Shimada et al. · Expert Opinion on Orphan Drugs · 2015 · 72 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +10

Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-Glycoprotein after high-dose steroid therapy

Tsutomu Shimada, Ai Terada, Koiçhi Yokogawa et al. · Transplantation · 2002 · 71 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetic advantage of intraperitoneal injection of docetaxel in the treatment for peritoneal dissemination of cancer in mice

Tsutomu Shimada, Masaaki Nomura, Koiçhi Yokogawa et al. · Journal of Pharmacy and Pharmacology · 2005 · 61 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer

Yutaka Yonemura, Yoshio Endou, Etsurou Bando et al. · Cancer Letters · 2004 · 47 citations

Medicine, Oncology, Surgery +15